MILBEMYCIN BETA11

ID: ALA1651947

Max Phase: Preclinical

Molecular Formula: C31H46O7

Molecular Weight: 530.70

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Milbemycin Beta11
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CC1=C[C@H]2C(=O)O[C@H]3C[C@@H](C/C=C(\C)C[C@@H](C)/C=C/C=C(\C)[C@]2(O)[C@H](O)[C@@H]1O)O[C@@]1(CC[C@H](C)[C@@H](C)O1)C3

    Standard InChI:  InChI=1S/C31H46O7/c1-18-8-7-9-22(5)31(35)26(15-21(4)27(32)28(31)33)29(34)36-25-16-24(11-10-19(2)14-18)38-30(17-25)13-12-20(3)23(6)37-30/h7-10,15,18,20,23-28,32-33,35H,11-14,16-17H2,1-6H3/b8-7+,19-10+,22-9+/t18-,20-,23+,24+,25-,26-,27+,28+,30-,31+/m0/s1

    Standard InChI Key:  BAYQGUBTKMOTSJ-WZCFKJIISA-N

    Associated Targets(non-human)

    ATP binding cassette transporter Abc1p 50 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 530.70Molecular Weight (Monoisotopic): 530.3244AlogP: 4.52#Rotatable Bonds: 0
    Polar Surface Area: 105.45Molecular Species: NEUTRALHBA: 7HBD: 3
    #RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
    CX Acidic pKa: 12.44CX Basic pKa: CX LogP: 4.13CX LogD: 4.13
    Aromatic Rings: 0Heavy Atoms: 38QED Weighted: 0.31Np Likeness Score: 2.49

    References

    1. Lamping E, Ranchod A, Nakamura K, Tyndall JD, Niimi K, Holmes AR, Niimi M, Cannon RD..  (2009)  Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.,  53  (2): [PMID:19015352] [10.1128/aac.01095-08]

    Source